These findings, taken together with our previous observation that E2 has a novel antitumour effect on T47D/PKCα breast tumours (Chisamore et al, 2001), may have important therapeutic implications in the management of breast cancer patients. This evidence concerns the gene PRKCA and breast carcinoma.